FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients
The biowearable is designed to alert people of rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency, a serious health complication for people with diabetes
· 8/26/2026, 3:16:43 PM· 2 min read
The biowearable is designed to alert people of rising ketones that can lead to a diabetic ketoacidosis (DKA) emergency, a serious health complication for people with diabetes
Read original story →
